Top Key Players and Industry Analysis

Acne Drugs Market

Acne or acne vulgaris is a skin disease caused by clogging of hair follicles with dead skin cells and oil from skin cells. This disease is characterized by pimples, blackheads, oily skin and scars. There are two types of acne, non-inflammatory acne and inflammatory acne, the latter of which takes longer to heal and can have permanent effects on the skin. It usually affects skin with a relatively high number of sweat glands such as the upper chest, back, and face. Acne medications are medications indicated for the treatment of acne. These include several prescription and over-the-counter medications such as retinoids, isotretinoin, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives. According to Verified Market Research, Global Acne Drugs Market was valued at USD 11,865.9 Million in 2019 and is projected to reach USD 13,357.57 Million by 2027 at a CAGR of 3.80% from 2020 to 2027.

Request a free sample report at:

Rising prevalence of acne vulgaris globally, unhealthy urban lifestyle, increasing pollution and emphasis on skin care products are the major factors driving the growth of the market. However, the side effects associated with acne medications and reforms and the presence of alternative treatment options such as laser therapies are hampering the growth of the market. Conversely, the development of new products with fewer side effects and the presence of an untapped market in emerging economies are expected to provide lucrative growth opportunities for the acne medication market.

This pandemic has disrupted the growth of many economies in various areas. The impact of the COVID-19 pandemic has remained negative for major players in the acne medication market. However, many dermatology clinics are facing difficulty due to the lockdown, which has led to a drop in the number of patient visits to the clinics. However, this deleterious impact is compensated by certain means with the use of telemedicine.

By therapeutic class, the retinoids segment accounted for the largest share in 2019. Retinoids are most effective for moderate to severe acne because they unclog pores, allowing topical creams and gels to work better. Additionally, retinoids decrease post-inflammatory hyperpigmentation, while simultaneously preventing any new acne from forming on the skin. However, the salicylic acid segment is expected to grow at the highest CAGR from 2020 to 2027.

The global acne medication market is segmented into therapeutic class, formulation, type, acne type, distribution channel, and region. By therapeutic class, the market is divided into retinoids, antibiotics, salicylic acid, benzoyl peroxide and others. The retinoid segment is further classified into topical retinoid and combination retinoid and oral retinoid (is otretinoin). Moreover, the antibiotics segment is further sub-segmented into topical antibiotics, combination antibiotics, and oral antibiotics. Based on formulation, the market is divided into topical medications and oral medications. By type, it is divided into prescription drugs and over-the-counter (OTC) drugs. By type of acne, it is fragmented into non-inflammatory and inflammatory acne. By distribution channel, it is classified into retail store, pharmacy and parapharmacy and e-commerce. Regionally, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.

On the basis of type, currently prescription drugs segment is the revenue generating segment in the market. Prescription acne products such as antibiotics are usually combined with benzoyl peroxide or topical retinoid which is an effective combination, which is driving the prescription acne medication market over the forecast period. On the other hand, the OTC segment is expected to register a CAGR of 3.20% during the forecast period, owing to the increasing preference of the patient population for the use of OTC products. over-the-counter (OTC) as they are convenient to purchase and expensive in nature, which is propelling the growth of the acne medication market.

North America accounted for the largest revenue share in 2019 and is expected to maintain its dominance from 2020 to 2027, due to numerous developments related to acne treatments. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, due to increased number of product launches, high demand for acne treatments and rising healthcare costs as well as increased awareness of newly developed therapies that can replace conventional therapies. treatment of acne in this region.

For a purchase request to:

Main results of the study:
The study provides an in-depth analysis of the global acne medication market with current trends and future estimates from 2019 to 2027 to elucidate the impending investment pockets.

A comprehensive analysis of factors driving and restraining the Acne Drugs Market growth is provided.

Identification of driving factors to change the market scenario, rise in opportunities and identification of key companies that can influence this market on a global and regional scale are provided.

Key players are profiled and their strategies are thoroughly analyzed to understand the competitive outlook of the Acne Drugs market.

Main market players:
The report provides some of the major players operating in the market including Almirall SA., Bausch Health Companies Inc., GlaxoSmithKline Plc (GSK), Johnson & Johnson, Galderma SA, Mayne Pharma Group Limited, Mylan NV, Pfizer Inc., Sun Pharmaceutical Industries Limited and Teva Pharmaceutical Industries Ltd

Other trend reports:
Medical Nutrition Market in Vietnam-

US Portable Ventilator Market-

Cough Syrup Market-

David Correa
5933 NE Win Sivers Drive
205 Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
The Web:

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unparalleled quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market area.
AMR introduces its premium subscription-based online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

This press release was published on openPR.

Comments are closed.